ETF Market Overview - The overall performance of ETF products has been good in the past two weeks, with the largest increase seen in the ChiNext Index ETF and the pharmaceutical industry ETF [4][12] - Major broad-based ETFs such as the Science and Technology 50, CSI 2000, and CSI 800 saw net inflows, while the CSI A500 ETF experienced the largest net outflow [4][12] - After significant outflows at the beginning of the year, technology ETFs have shifted to net inflows since March, with a notable acceleration in inflow speed in the last two weeks [4][20] ETF Product Structure Distribution - As of July 11, 17 new ETFs were launched in the past two weeks, with a total issuance of 31.823 billion units, including 7 stock ETFs and 10 pure bond ETFs [27] - Compared to the end of 2024, the scale of various ETFs has increased, with bond ETFs, commodity ETFs, industry + dividend ETFs, QDII ETFs, and broad-based ETFs rising by 132.25%, 111.16%, 29.00%, 14.05%, and 2.70% respectively [27] Thematic ETF Tracking - In the technology theme ETFs, products tracking animation and gaming performed best, while overseas technology ETFs underperformed compared to domestic ones [33] - For dividend theme ETFs, those tracking the CSI Central State-Owned Enterprise Dividend had the highest return in the past two weeks, with significant net inflows for products tracking low-volatility dividend indices [4][33] - In the pharmaceutical theme ETFs, products tracking innovative drug indices showed strong performance, with net inflows for those tracking Hong Kong Stock Connect innovative drug indices [4][33] Fund Manager Scale Distribution - As of July 11, Huaxia Fund has the largest ETF scale at 762.281 billion yuan, while E Fund's ETF management scale has expanded by over 290 billion yuan compared to one year ago [28]

Group 1: Market Sentiment on Pharmaceutical Stocks - There is a significant divergence among fund managers regarding pharmaceutical stocks, particularly in valuation and performance realization, innovation drug development risks and returns, market sentiment and capital flow, policy impacts, and short-term volatility [2][10] - Some fund managers are opting for swing trading in the pharmaceutical sector, with specific examples like Dongfang Biological, which saw a 5.56% increase in Q2 [4][10] - Notable fund managers have either increased or decreased their holdings in specific pharmaceutical companies, such as Wan Minyuan increasing his stake in Dongfang Biological while others like Wu Yuanyi reduced their holdings [5][6][8] Group 2: Military Industry Focus - There has been an increased interest from public funds in the military sector, with notable fund managers like Li Xiaoxing and Chen Yunzhong increasing their positions in companies like Jingpin Special Equipment [11][12] - The military sector has seen a surge in trading activity, with a record weekly trading volume of 4,298.88 billion yuan, indicating heightened market interest [15][16] - The military industry is expected to remain a focal point for market participants, presenting structural opportunities despite potential short-term volatility risks [16] Group 3: Investment Strategies and Future Outlook - Fund managers are focusing on sectors such as dividends, technology growth, and innovative pharmaceuticals for the upcoming quarter, with expectations of a resilient market and structural opportunities [18][19] - The innovative pharmaceutical sector is viewed as having the greatest potential, with opportunities arising from potential corrections in leading innovative pharmaceutical companies [19][20] - The banking sector is also highlighted as a core direction for high dividends, with many A-share banks offering dividend yields above 4.5% [20]

Report Information - Report Title: Weekly Report on Capital Flows of Exchange-Traded Index Funds [1] - Data Date: June 30, 2025 - July 4, 2025 [1] - Analyst: Jin Ling [1] - Report Date: July 8, 2025 [1] Core Content Domestic Passive Stock Funds - **Composite and Industry Themes**: Different concepts have varying fund sizes, weekly price changes, and net weekly capital inflows. For example, the SSE 50 has a fund size of 159.456 billion yuan, a weekly increase of 1.41%, and a net weekly capital outflow of 2.765 billion yuan; the large technology concept has a fund size of 216.688 billion yuan, a weekly decrease of 0.32%, and a net weekly capital inflow of 6.066 billion yuan [4]. - **Style Strategies and Other Categories**: Similar to the above, different concepts show different performance. For instance, the dividend low - volatility concept has a fund size of 43.535 billion yuan, a weekly increase of 1.82%, and a net weekly capital inflow of 1.419 billion yuan [4]. Overseas - Related Funds - **Composite and Industry Themes**: Concepts like the Nasdaq 100 have a fund size of 78.421 billion yuan, a weekly increase of 1.04%, and a net weekly capital outflow of 0.032 billion yuan; the Hong Kong stock technology concept has a fund size of 92.609 billion yuan, a weekly decrease of 2.43%, and a net weekly capital inflow of 2.88 billion yuan [5]. - **Style Strategies**: The dividend concept has a fund size of 126.9 million yuan, a weekly increase of 0.99%, and a net weekly capital inflow of 0.0016 billion yuan; the dividend low - volatility concept has a fund size of 77.7 million yuan, a weekly increase of 1.26%, and a net weekly capital inflow of 0.00154 billion yuan [5]. Other Investment Types - **Bonds**: Different maturities and types of bonds have different performances. For example, 30 - year bonds have a fund size of 8.969 billion yuan, a weekly increase of 0.18%, and a net weekly capital inflow of 0.0257 billion yuan; convertible bonds have a fund size of 43.859 billion yuan, a weekly increase of 1.05%, and a net weekly capital outflow of 0.0098 billion yuan [6]. - **Commodities**: Gold has a fund size of 70.887 billion yuan, a weekly increase of 1.13%, and a net weekly capital inflow of 2.252 billion yuan; energy and chemical products have a fund size of 293 million yuan, a weekly decrease of 0.37%, and a net weekly capital outflow of 0.0093 billion yuan [6]. - **Index Enhancement**: Different index - related concepts also show different trends. For example, the SSE 50 index - enhanced concept has a fund size of 76 million yuan, a weekly increase of 2.55%, and no net weekly capital inflow or outflow [6].

Group 1 - The core viewpoint of the article highlights the strong performance of both domestic and overseas equity markets in recent weeks, driven by multiple factors including easing risk factors and improving market sentiment, leading to a continuous upward trend [2][3] - Various strategy indices have recorded positive returns, with the Evergreen Low Volatility Strategy and Stock Enhancement Strategy achieving returns of 1.19% and 1.26% respectively, outperforming the CSI All Share Index [2][3] - The A-share market has shown optimism as the Shanghai Composite Index rebounded to around 3500 points, with technology growth sectors showing signs of stabilization after previous adjustments [3][4] Group 2 - The quantitative strategy allocation suggests prioritizing Stock Enhancement Strategy over Evergreen Low Volatility Strategy and Overseas Equity Strategy, indicating a preference for more elastic strategies in the current market environment [3] - The Evergreen Low Volatility Fund Strategy has demonstrated strong stability and has been effective in reducing portfolio volatility while maintaining decent returns since its strategy implementation [11][23] - The Stock Enhancement Fund Strategy has shown potential for better performance as market conditions improve, with a focus on identifying undervalued companies [12][24] Group 3 - The Overseas Equity Allocation Fund Strategy has recorded a return of 1.1%, with the potential for further gains as the U.S. economy remains stable and technological advancements continue to drive growth [7][18] - The Cash Enhancement Fund Strategy has consistently outperformed its benchmark, accumulating excess returns since its strategy implementation [6][16] - The article emphasizes the importance of a diversified global investment approach, particularly in light of the ongoing developments in the U.S. market and the potential for new growth opportunities [4][26]

Group 1: Company Actions - Huachuang Yinxin plans to cancel 10.8874 million repurchased shares and reduce its registered capital, changing total share capital from 2.224 billion shares to 2.214 billion shares, with a capital reduction of 10.8874 million yuan [1] - The cancellation of repurchased shares aims to optimize the capital structure and enhance investor confidence, potentially positively impacting the company's stock price [1] Group 2: Fund Performance - Over 80% of public funds reported net value growth in the first half of 2025, with many products exceeding an 80% growth rate, while the overall market scale remains above 32 trillion yuan, marking a historical high [2] - The steady growth in equity fund scale reflects a gradual increase in investor risk appetite, while bond funds continue to dominate new product issuances [2] Group 3: New Fund Issuances - A total of 33 new funds are set to be issued this week, with index funds making up 23 of them, indicating strong market interest in structural trends [3] - The new index funds cover popular sectors such as automotive, AI, and pharmaceuticals, suggesting potential impacts on related company stock prices and increased market liquidity [3] Group 4: International Expansion - Xingzheng Global Fund has received approval to establish a subsidiary in Singapore, with a registered capital of 10 million Singapore dollars, indicating an acceleration in its internationalization strategy [4] - The appointment of Xie Zhiyu as chairman of the new subsidiary reflects the company's focus on strategic planning and enhances its competitiveness in overseas markets [4][5]

Market Overview - The A-share market ended the first half of the year positively, with the Shanghai Composite Index rising by 0.59% to close at 3444.43 points, and the Shenzhen Component Index increasing by 0.83% [1] - Overall, the market exhibited a trend of oscillating upward, with major indices showing slight gains [1] - The Shanghai Composite Index rose by 2.76% in the first half, while the Shenzhen Component Index increased by 0.48%, the ChiNext Index by 0.53%, and the STAR 50 Index by 1.46%. The North Star 50 Index stood out with a significant increase of 39.45% [1] Sector Performance - In the first half, 26 out of 31 Shenwan first-level industries saw an increase, with the top five sectors being Beauty Care (24.5%), Nonferrous Metals (23.1%), National Defense and Military Industry (20%), Media (19.1%), and Machinery Equipment (17.8%) [1] - The market displayed a "dividend + small-cap growth" style, with banks and gold stocks leading the gains, while technology growth sectors such as AI, semiconductors, solid-state batteries, and innovative drugs showed strong rotation [1] Individual Stock Performance - Over 3800 stocks rose in the first half, accounting for approximately 70% of the total, with 626 stocks increasing by over 50% and 175 stocks rising by more than 100% [1] - The top five individual stocks in terms of growth were Xingtum Measurement and Control, Guangxin Technology, United Chemical, Tiangong Co., and Shutaishen, all of which saw increases exceeding four times their initial values [2] Future Outlook - Analysts expect the market to continue the small-cap style led by private equity funds in the short term, with a potential shift towards large-cap growth style as external liquidity improves and economic fundamentals recover, possibly around the fourth quarter [2] - Key areas for accelerated growth include AI hardware and applications, humanoid robots, solid-state batteries, domestic semiconductor innovation, controllable nuclear fusion, military trade overseas, and new consumption [2]

Group 1 - As of June 29, over 80% of public funds have achieved positive returns in 2025, with the top fund, Huatai-PineBridge Hong Kong Advantage Selection, showing a remarkable increase of 89.15% [1] - The competition among public funds is intense, with the top two funds having an 8 percentage point difference in returns, while the third to fifth funds have a narrower margin of only 2 percentage points [1] - The leading funds over the past three to five years have shown significant growth, with Jin Yuan Shun An Yuan Qi achieving nearly 300% over five years, surpassing the second-place fund by over 90 percentage points [1] Group 2 - Approximately 80% of public funds with over 50% returns this year were heavily invested in the pharmaceutical sector by the end of Q1 2025, particularly in innovative drug companies [2] - The top fund, Huatai-PineBridge Hong Kong Advantage Selection, had all of its top ten holdings in innovative drug stocks, with notable performers like Rongchang Bio and Nuo Cheng Jian Hua seeing increases of up to 285.76% [2] - The fund manager emphasized that innovative drugs will be a crucial theme in the pharmaceutical industry for the coming years, focusing on companies with core competitiveness and long-term growth potential [2] Group 3 - The third-ranked fund, Great Wall Pharmaceutical Industry Selection, also focused on innovative drugs, with all top ten holdings showing over 30% gains this year [3] - The fund manager noted that the current landscape for innovative drug stocks is favorable due to advancements in overseas collaborations and improved financial reports [3] - The fund's strategy includes investing in companies with disruptive innovations and those that have begun commercializing their products, leading to rapid financial improvements [3] Group 4 - Two funds heavily invested in the Beijing Stock Exchange have performed well, with CITIC Securities Beijing Stock Exchange Selection achieving a return of 81.59% and Huaxia Beijing Stock Exchange Innovative Small and Medium Enterprises Selection at 71.92% [4] - The top ten holdings of CITIC Securities fund have all shown positive returns, with seven stocks increasing over 30%, and one stock, Wantong Hydraulic, exceeding 90% [4] - The fund manager expressed optimism about the long-term investment potential of companies listed on the Beijing Stock Exchange, despite the need for cautious positioning in uncertain market conditions [4] Group 5 - Many of the top-performing public funds this year are small-scale products, with half of the top ten funds having a size of less than 100 million yuan [5] - In larger funds, performance is often driven by index products, with several ETFs showing strong returns [5] - The relationship between fund size and performance suggests that larger funds may dilute their aggressive investment strategies due to the need to diversify holdings [6] Group 6 - Among actively managed equity funds with over 10 billion yuan, only a few have achieved returns exceeding 10% this year, indicating challenges faced by larger funds [6] - Industry experts suggest that larger funds may struggle to adapt quickly to market changes, impacting their performance [6] - Looking ahead, many fund companies believe that investment opportunities in A-shares will outweigh risks, with a focus on sectors like technology, pharmaceuticals, and consumer goods [6]

NO.2开源证券：继续看好券商板块 开源证券指出，提经济、稳股市政策态度延续，货币政策适度宽松，证券行业基本面向好，估值处于低 位，基准约束有望带来资金回补，当下继续看好券商板块。选股方面推荐三条主线：(1)低估值、零售 业务具有优势的头部券商；(2)高beta弹性的金融科技标的；(3)受益于港股市场IPO扩容和活跃度提升的 香港交易所及海外业务占比高的头部券商。 ｜2025年6月27日星期五｜ NO.1华西证券：红利、科技、消费、军工等品种均值得关注 华西证券（002926）指出，本轮行情快速上涨，主要是稳市资金流入后，市场上修波动预期的结果。在 此前的低波预期下，"稳市资金推动行情企稳"这一增量信息足以对行情形成超预期推动效果。从两轮行 情的复盘来看，本轮行情适合以分散化的方式博弈，红利、科技、消费、军工等品种均值得关注；同 时，若市场在大幅上涨后动能减弱，隐含波动率大幅回落，则可能是观点分歧&行情切换的转折点。 NO.3中信证券：运营商电信业务整体回暖，看好运营商基本面改善 中信证券研报表示，2025年前5个月，通信业经济运行数据逐月提升(工信部)：电信业务收入累计完成 7488亿元，同比增长1.4%( ...

Core Viewpoint - The article discusses the performance of the A-share market, particularly the challenges of the Shanghai Composite Index reaching 3400 points, and emphasizes the importance of looking beyond this index to understand the overall market dynamics and investment opportunities. Market Performance - The A-share and Hong Kong markets showed resilience despite regional conflicts, with the Shanghai Composite Index and the CSI 300 experiencing slight increases [2][3][4]. - The article notes that the Shanghai Composite Index has fluctuated around key levels, with historical references to its struggles to surpass 2000 and 3000 points in the past [5][8]. Index Significance - The Shanghai Composite Index began around 100 points in 1990, and its value is driven by earnings growth over time [9]. - The article highlights that the Shanghai Composite Index is not representative of the overall A-share market performance, as it does not capture the full spectrum of returns available to investors [10][12]. Investment Strategies - The article mentions that the CSI 300 and other indices like the CSI 500 are more reflective of the broader market, with the CSI 300 index fund exceeding 1 trillion yuan in scale [14][15]. - It discusses the performance of various strategy indices, such as dividend and value strategies, which have outperformed the Shanghai Composite Index [18]. Future Outlook - The article suggests that discussions may soon shift to when the Shanghai Composite Index will reach 4000 or 5000 points, indicating a long-term bullish outlook [9]. - It emphasizes the need for investors to consider a wider range of indices and strategies to fully capture the investment potential in the A-share market [18].

风险提示： 理财赎回风险；转债转股溢价率压缩风险；转债正股表现不及预期。 报告来源 以上内容节选自国泰海通证券已发布的证券研究报告。 报告名称： 估值蓄力，坚守主线——转债市场点评 报告日期：2025.06.17 报告作者： 顾一格 （分析师），登记编号： S0880522120006 报告导读： 当前转债估值较4月初略有下降，性价比有所提升。建议通过布局自主可 控、内需发力和红利三条主线降低关税影响，提前布局优质底仓替代标的。 5月12日中美日内瓦协议落地以来，权益市场并未大涨，而是维持窄幅波动。 我们认为一方面是因为关税 摩擦缓和预期已经在4月8日-5月12日的反弹中被市场充分定价，另一方面，市场担心2018年中美达成协议 后美方单方面撕毁协议的情况再次发生。事实上，自中美日内瓦经贸会谈以来，美方新增多项对华限制措 施，包括发布AI芯片出口管制指南、停止对华芯片设计软件销售、宣布撤销中国留学生签证等。在刚刚结 束的中美伦敦会谈中，就落实两国元首6月5日通话重要共识和巩固日内瓦经贸会谈成果的措施框架达成原 则一致，就解决双方彼此经贸关切取得新进展。紧张关系暂时缓和，但结构性矛盾仍未根本性解决。中美 之间的结 ...